Rhumbline Advisers Johnson & Johnson Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
A detailed history of Rhumbline Advisers transactions in Johnson & Johnson stock. As of the latest transaction made, Rhumbline Advisers holds 4,214,532 shares of JNJ stock, worth $644 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
4,214,532
Previous 4,245,541
0.73%
Holding current value
$644 Million
Previous $688 Million
11.41%
% of portfolio
0.56%
Previous 0.63%
Shares
30 transactions
Others Institutions Holding JNJ
# of Institutions
4,309Shares Held
1.68BCall Options Held
17.7MPut Options Held
14.5M-
Vanguard Group Inc Valley Forge, PA231MShares$35.3 Billion0.69% of portfolio
-
Black Rock Inc. New York, NY198MShares$30.3 Billion0.67% of portfolio
-
State Street Corp Boston, MA134MShares$20.5 Billion0.9% of portfolio
-
Geode Capital Management, LLC Boston, MA56.1MShares$8.58 Billion0.75% of portfolio
-
Morgan Stanley New York, NY45.2MShares$6.9 Billion0.54% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $400B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...